BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singhvi G, Girdhar V, Patil S, Gupta G, Hansbro PM, Dua K. Microbiome as therapeutics in vesicular delivery. Biomedicine & Pharmacotherapy 2018;104:738-41. [DOI: 10.1016/j.biopha.2018.05.099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee AJ, Einarsson GG, Gilpin DF, Tunney MM. Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis? Front Pharmacol 2020;11:569821. [PMID: 33013411 DOI: 10.3389/fphar.2020.569821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li P, Bukhari SNA, Khan T, Chitti R, Bevoor DB, Hiremath AR, SreeHarsha N, Singh Y, Gubbiyappa KS. Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway. Int J Nanomedicine 2020;15:9115-24. [PMID: 33244230 DOI: 10.2147/IJN.S256494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chellappan DK, Sze Ning QL, Su Min SK, Bin SY, Chern PJ, Shi TP, Ee Mei SW, Yee TH, Qi OJ, Thangavelu L, Rajeshkumar S, Negi P, Chellian J, Wadhwa R, Gupta G, Collet T, Hansbro PM, Dua K. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases. Chemico-Biological Interactions 2019;310:108732. [DOI: 10.1016/j.cbi.2019.108732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
4 Fu JL, Yu Q, Li MD, Hu CM, Shi G. Deleterious cardiovascular effect of exosome in digitalis-treated decompensated congestive heart failure. J Biochem Mol Toxicol 2020;34:e22462. [PMID: 32045083 DOI: 10.1002/jbt.22462] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Dua K, Rapalli VK, Shukla SD, Singhvi G, Shastri MD, Chellappan DK, Satija S, Mehta M, Gulati M, Pinto TDJA, Gupta G, Hansbro PM. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches. Biomedicine & Pharmacotherapy 2018;107:1218-29. [DOI: 10.1016/j.biopha.2018.08.101] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
6 Luan Z, Liu B, Shi L. Angiotensin II-induced micro RNA-21 culprit for non-small-cell lung adenocarcinoma. Drug Dev Res 2019;80:1031-9. [PMID: 31823412 DOI: 10.1002/ddr.21597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Hassan Almalki W, Alzahrani A, Mahmoud El-Daly ME, Faissal Fadel Ahmed AH. A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional β-adrenergic and ATP-sensitive K+ channel activity in cardiovascular compromised preterm infants. J Biochem Mol Toxicol 2021;:e22849. [PMID: 34309957 DOI: 10.1002/jbt.22849] [Reference Citation Analysis]
8 Khangwal I, Shukla P. Potential prebiotics and their transmission mechanisms: Recent approaches. Journal of Food and Drug Analysis 2019;27:649-56. [DOI: 10.1016/j.jfda.2019.02.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]